Abstract:Diabetes mellitus, linked with insulin resistance and hyperglycaemia, is a leading cause of mortality. Glucose uptake through glucose transporter type 4, especially in skeletal muscle, is crucial for maintaining euglycaemia and is a key pathway targeted by antidiabetic medication. Abrus precatorius is a medicinal plant with demonstrated antihyperglycaemic activity in animal models, but its mechanisms are unclear. This study evaluated the effect of a 50% ethanolic ( v/v ) A. precatorius leaf extract on (1) insulin-stimulated glucose uptake and (2) related gene expression in differentiated C2C12 myotubes using rosiglitazone as a positive control, and (3) generated a comprehensive phytochemical profile of A. precatorius leaf extract using liquid chromatography-high resolution mass spectrometry to elucidate its antidiabetic compounds. A. precatorius leaf extract significantly increased insulin-stimulated glucose uptake, and insulin receptor substrate 1 and Akt substrate of 160 kDa gene expression; however, it had no effect on glucose transporter type 4 gene expression. At 250 μg/mL A. precatorius leaf extract, the increase in glucose uptake was significantly higher than 1 μM rosiglitazone. Fifty-five phytochemicals (primarily polyphenols, triterpenoids, saponins, and alkaloids) were putatively identified, including 24 that have not previously been reported from A. precatorius leaves. Abrusin, precatorin I, glycyrrhizin, hemiphloin, isohemiphloin, hispidulin 4′- O - β -D-glucopyranoside, homoplantaginin, and cirsimaritin were putatively identified as known major compounds previously reported from A. precatorius leaf extract. A. precatorius leaves contain antidiabetic phytochemicals and enhance insulin-stimulated glucose uptake in myotubes via the protein kinase B/phosphoinositide 3-kinase pathway by regulating insulin receptor substrate 1 and Akt substrate of 160 kDa gene expression. Therefore, A. precatorius leaves may improve skeletal muscle insulin sensitivity and hyperglycaemia. Additionally, it is a valuable source of bioactive phytochemicals with potential therapeutic use for diabetes. Determination of noncytotoxic concentrations of APLE, gene expression studies (RNA isolation, primers), and HR LC-MS analysis (instrumentation and operating conditions, data processing, dereplication, putative identification of metabolites) as well as cell viability of C2C12 myotubes treated with 1 – 500 μg/mL APLE over 24 h, phytochemicals putatively identified from APLE (in increasing order of measured neutral mass) with details of the retention time, mass, putative identity, and phytochemical class of metabolites detected from APLE, previously reported antidiabetic properties of phytochemicals putatively identified from APLE, a summary of studies demonstrating the effect of APLE phytochemicals on muscle glucose uptake, and additional references supporting the methodology, putative identity of phytochemicals, and their bioactivity are available as Supporting Information. Received: 24 September 2023 Accepted after revision: 26 February 2024 Article published online: 15 March 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

α-amyrin induce GLUT4 translocation mediated by AMPK and PPARδ/γ in C2C12 myoblasts.

Paeonol Ameliorates Glucose and Lipid Metabolism in Experimental Diabetes by Activating Akt

AMPK/AS160 Mediates Tiliroside Derivatives-Stimulated GLUT4 Translocation in Muscle Cells

DHA/EPA Improves GLUT4 Translocation, Glycogen Synthesis and Aerobic Glycolysis in Skeletal Muscle of Db/db Mice

A novel indole derivative compound GY3 improves glucose and lipid metabolism via activation of AMP-activated protein kinase pathway.

Enhancement of Glucose Utilization by Loesenerine Through AMPK Activation in Myotubes.

Alisol A-24-acetate promotes glucose uptake via activation of AMPK in C2C12 myotubes

Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway

Ameliorative effects of mangiferin derivative TPX on insulin resistance via PI3K/AKT and AMPK signaling pathways in human HepG2 and HL-7702 hepatocytes

Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway

Acacetin enhances glucose uptake through insulin-independent GLUT4 translocation in L6 myotubes

Cyclocarya paliurus triterpenoids suppress hepatic gluconeogenesis via AMPK-mediated cAMP/PKA/CREB pathway

Hernandezine, a Natural Herbal Alkaloid, Ameliorates Type 2 Diabetes by Activating AMPK in Two Mouse Models.

Antidiabetic effects of betulinic acid mediated by the activation of the AMP-activated protein kinase pathway

Novel Small-Molecule Ampk Activator Orally Exerts Beneficial Effects on Diabetic Db/Db Mice

Proteoglycan Extracted from Ganoderma Lucidum Ameliorated Diabetes-Induced Muscle Atrophy Via the AMPK/SIRT1 Pathway in Vivo and in Vitro

Discovery of seneciobipyrrolidine derivatives for the amelioration of glucose homeostasis disorders through 4E-BP1/Akt/AMPK signaling activation.

Γ‐glutamylcysteine Alleviates Insulin Resistance and Hepatic Steatosis by Regulating Adenylate Cyclase and IGF‐1R/IRS1/PI3K/Akt Signaling Pathways

Enhancing β-Cell Function and Identity in type 2 diabetes: The Protective Role of Coptis deltoidea C. Y. Cheng et Hsiao via Glucose Metabolism Modulation and AMPK Signaling Activation

α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism

Abrus precatorius Leaf Extract Stimulates Insulin-mediated Muscle Glucose Uptake: In vitro Studies and Phytochemical Analysis